Rossmax International Ltd

Rossmax International Ltd has a market price of TWD 14.55 and a market cap of TWD 1.2 billion, with a price-to-book ratio of 0.85 and a price-to-tangible-book ratio of 0.85, indicating a discount to its book value. The company's liquidity position is characterized by TWD 613.7 million in cash and equivalents, but its long-term debt of TWD 1.34 billion exceeds its cash reserves, resulting in a negative net cash position. The current ratio of 1.92 suggests moderate short-term liquidity, but the debt-to-equity ratio of 0.95 highlights a leveraged capital structure. Profitability metrics show a challenging operating environment, with a net loss of TWD 29.9 million and an operating loss of TWD 73.7 million in the latest period. Return on equity is negative at -2.12%, and return on assets is also negative at -0.71%, both significantly below the industry median for medical equipment firms. Gross profit of TWD 1.31 billion represents 34.4% of revenue, which is in line with industry norms but insufficient to offset operating costs. The company's revenue is derived from four main product segments: digital sphygmomanometers, respiratory therapy products, temperature series products, and blood oxygen meters. While the input data does not provide segment-specific revenue figures, the disclosed product mix suggests a diversified approach to medical device manufacturing. Geographically, Rossmax distributes its products in the domestic market and to overseas markets, including Europe and the Americas, but the input data does not specify the proportion of revenue from each region. Looking ahead, the company's growth trajectory is uncertain. The latest financial data shows a net loss and negative operating income, with no clear indication of a turnaround in the near term. The absence of revenue growth data and the lack of segment-specific outlooks make it difficult to assess future performance. The company's capital expenditure of TWD -47.46 million suggests a reduction in investment, which may reflect cost-cutting measures or a strategic shift. Risk factors include a leveraged capital structure, with long-term debt exceeding cash reserves, and a negative net income, which could pressure liquidity and increase reliance on external financing. The risk assessment flags a negative net cash position as a key concern, and while dilution risk is currently rated as low, the company's financial performance could change this outlook if further capital is required. No recent filings or transcripts are provided to indicate material events or strategic shifts. The company's recent financial performance and capital structure suggest a need for close monitoring of liquidity and profitability. The negative net income and operating loss highlight the importance of tracking future earnings and cash flow trends to assess the company's ability to service debt and maintain operations.